CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Capex Y/Y Annual
Cardiff Lexington Corporation  (CDIF)
Other Ticker:  
 
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

CDIF's Capital Expenditures Growth by Quarter and Year

Cardiff Lexington's Capital Expenditures results by quarter and year




CDIF Capital Expenditures (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December 0.00 0.00 0.00 0.00
III Quarter September 0.00 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   0.00 0.00 0.00 0.00



CDIF Capital Expenditures fourth quarter 2024 Y/Y Growth Comment
Cardiff Lexington Corporation in the fourth quarter 2024 recorded Capital Expenditures of $ 0.00 millions.

According to the results reported in the fourth quarter 2024, Cardiff Lexington Corporation achieved the best Capital Expenditures growth in Healthcare Facilities industry. While Cardiff Lexington Corporation' s Capital Expenditures no change of % ranks overall at the positon no. in the fourth quarter 2024.


CDIF Capital Expenditures ( Y/Y Growth %) 2024
 2023 2022 2021
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Cardiff Lexington's fourth quarter 2024 Capital Expenditures $ 0.00 millions CDIF's Income Statement
Cardiff Lexington's fourth quarter 2023 Capital Expenditures $ 0.00 millions Quarterly CDIF's Income Statement


CDIF Capital Expenditures (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -


Suppliers by CDIF Divisions >> Back to CDIF Growth rate Comparisons >>


Capital Expenditures fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #

Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Capital Expenditures fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Capital Expenditures by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Cardiff Lexington's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CDIF's IV. Quarter Q/Q Capital Expenditures Comment


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CDIF's IV. Quarter Q/Q Capital Expenditures Comment


Cardiff Lexington's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) - - - - -
Seq. Capital Expenditures Growth (TTM) Overall Ranking # # # # #


Cumulative Capital Expenditures growth Comment
In the Dec 31 2024 period, Cardiff Lexington's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Cardiff Lexington Corporation achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Capital Expenditures growth Comment
In the Dec 31 2024 period, Cardiff Lexington's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Cardiff Lexington Corporation achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Capital Expenditures Growth
Healthcare Facilities Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
CDIF's Capital Expenditures Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for CDIF's Competitors
Capital Expenditures Growth for Cardiff Lexington's Suppliers
Capital Expenditures Growth for CDIF's Customers

You may also want to know
CDIF's Annual Growth Rates CDIF's Profitability Ratios CDIF's Asset Turnover Ratio CDIF's Dividend Growth
CDIF's Roe CDIF's Valuation Ratios CDIF's Financial Strength Ratios CDIF's Dividend Payout Ratio
CDIF's Roa CDIF's Inventory Turnover Ratio CDIF's Growth Rates CDIF's Dividend Comparisons



Companies with similar Capital Expenditures no change for the quarter ending Dec 31 2024 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Dec 31 2024
Healthcare Services Group Inc -0.42%$ -0.419 millions
Community Health Systems Inc -0.91%$ -0.909 millions
Precigen Inc -1.63%$ -1.627 millions
National Vision Holdings Inc -2.40%$ -2.405 millions
Prime Medicine Inc -2.66%$ -2.663 millions
Quidelortho Corp-2.88%$ -2.881 millions
Charles River Laboratories International inc -3.46%$ -3.456 millions
West Pharmaceutical Services Inc -3.50%$ -3.496 millions
Regenxbio Inc -4.17%$ -4.174 millions
Abbott Laboratories-4.64%$ -4.636 millions
Aurinia Pharmaceuticals Inc -5.08%$ -5.085 millions
Inmode Ltd -5.11%$ -5.106 millions
National Healthcare Corp-5.17%$ -5.174 millions
Merck and Co Inc -5.26%$ -5.258 millions
Catalyst Pharmaceuticals Inc -5.38%$ -5.376 millions
Aura Biosciences Inc -5.68%$ -5.678 millions
Anaptysbio Inc -6.07%$ -6.071 millions
Aquestive Therapeutics Inc -6.25%$ -6.250 millions
Immunoprecise Antibodies Ltd -6.56%$ -6.555 millions
Dar Bioscience Inc -7.32%$ -7.324 millions
Pluri Inc-7.44%$ -7.438 millions
Henry Schein Inc -7.69%$ -7.692 millions
Iqvia Holdings Inc -8.38%$ -8.380 millions
Interpace Biosciences Inc -9.15%$ -9.155 millions
Lifevantage Corp-9.39%$ -9.392 millions
Becton Dickinson And Company-9.48%$ -9.483 millions
Edap Tms Sa-9.81%$ -9.807 millions
Repligen Corp-10.10%$ -10.102 millions
Precipio inc -10.20%$ -10.204 millions
Encompass Health Corporation-10.74%$ -10.737 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com